Extract SBIR Microbiome Budget Intelligence via FOIA & Competitive Scraping
- Organization
- NSF SBIR Program - awarding $305k to ENDURE BIOTHERAPEUTICS with non-public budget details
- Sector
- Specialized CROs, CDMOs, investors, and competing biotechs needing intelligence on SBIR-funded microbiome spending
- Location
- Carlsbad, CA
Source reference
Executive summary
Current state
ENDURE BIOTHERAPEUTICS received $305k SBIR Phase I funding for a microbiome-based PKU therapy, creating immediate capital for vendor procurement but exposing structural gaps in regulatory knowledge, patient engagement, and efficient spending of government funds within a 6-month deadline.
Market catalyst
ENDURE's $305k SBIR funding creates immediate demand for specialized CRO/CDMO services, but the exact budget allocation and vendor procurement plans are buried in non-public NSF documentation. Competitors, vendors, and investors need this intelligence to position themselves but lack access.
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.
Field notes
Intelligence ledger
Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.
Sign in to add intelligence or vote on a field note.
Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.